Treatments for rheumatic diseases have made significant progress thanks to increasingly targeted therapies, but critical issues remain related to early diagnosis, continuity of care, and equitable access to treatment. This is the finding of the meeting promoted by APMARR at the Ministry of Health in Rome, dedicated to the current and future challenges of rheumatology, with a focus also on antibiotic resistance and treatment safety.
https://www.youtube.com/watch?v=ohYB0O4o9oQ
